Sinclair Pharma
Sinclair Pharmaceuticals Limited is an innovative, research and development driven specialty pharmaceutical company that manufactures and distributes aesthetic products for skin rejuvenation.
Products
About the manufacturer
Sinclair Pharma has been committed to improving patients’ health, appearance, and confidence since its establishment in 1971. Sinclair, which has a background in dermatology, has gradually shifted its focus to facial aesthetics through a series of strategic acquisitions. The company designs, manufactures, and distributes products for aesthetic treatments, specifically dermal fillers for facial rejuvenation. Sinclair Pharma offers long-lasting, natural-looking, and minimally invasive treatments manufactured using the latest technologies.
Manufacturer’s brands
Sinclair Pharma’s iconic products include Ellanse and Perfectha.
Ellanse (S, M, L, E) is a line of injectable fillers that work as a biostimulator of collagen synthesis and are intended to slow down the aging process in the skin. Ellanse fillers are composed of synthetic polycaprolactone (PCL) and carboxymethyl cellulose. The results may last from 12 months to 4 years.
Perfectha line of hyaluronic acid dermal fillers (Fine Lines, Complement, Derm, Deep, and Subskin) is designed to provide long-lasting effects for the reduction of wrinkles, the restoration of lost volume, and facial contouring.
Major Medical Solutions offers to buy Ellanse and Perfectha and enjoy fast worldwide delivery and the best wholesale prices.
Manufacturer’s strengths
In order to provide a fantastic experience, Sinclair Pharma is constantly changing their business to meet the demands of the community of practitioners and their clients. Sinclair Pharma provides an exceptional range of scientifically proven, advanced aesthetic products and services designed exclusively for the global industry of highly skilled clinicians. This guarantees that the patients receive consistently outstanding, long-lasting results that enhance their appearance — and confidence.